Life Scan Executive Summary

Even though there are some parts that Eli Lilly fail on it but it try hard to understand what their customer really need. Eli Lilly found out that customer would willing to use their new product if they did some change to it such as more easy for customers to using new product or using other technology instead of need to inject. And more important is that Eli Lilly found out that most of their customers don’t have enough of information about diabetes care. So Eli Lilly set up an Controlled Diabetes Services program (CDS) which educating people and building a community of patients the value of their insulin therapy. I think Eli Lilly made a good decision about setting up CDS which can indirectly understand what their customers need and allow more people have more opportunity to get to know their product and use their product. Focusing on know their customer and educating their customer will let more and more people know their new product and form a habit of using their new product. If CDS successfully then Eli Lilly new product such as Match and Insulin pens will have less problem when it sales on the market.

Elasticity of demand is the relationship between the demands for a product with respect to its price. Generally, when the demand for a product is high, the price of the product decreases. When demand decreases, prices tend to climb. Products that exhibit the characteristics of elasticity of demand are usually cars, appliances and other luxury items. Items such as clothing, medicine and food are considered to be necessities. Essential items usually possess inelasticity of demand. When this occurs prices do not change significantly.

Elasticity : rising or falling price lead changes in quantity of demand, and the quantity of supply and this so-called elasticity

Diabetes has had a major impact on the lives of millions. The current treatments are invasive and sometimes unpredictable. With the human factor involved, occasionally the wrong dosage may be administered leading to adverse side effects. In an attempt to leave out the chance of human error and make the lives of those suffering from diabetes simpler, researchers at the University of North Carolina and NC State have jointly come up with a solution. The smart patch is a device the size of a penny capable of releasing insulin into capillaries using micro needles.

LifeScan, Inc. is one of Johnson & Johnson’s Diabetes Solution Companies. LifeScan was established in 1981 to develops products that improve the quality of life for millions of people diagnosed with Diabetes. LifeScan, Inc. is based in Milpitas, California with over 3,000 employees worldwide and manufacturing facilities in Puerto Rico, and Scotland (LifeScan, 2016). In 2009, LifeScan, Inc. released the OneTouch Ultra 2 Blood Glucose Monitoring Systems. In, 2015, Johnson & Johnson’s worldwide annual sales topped $8,094 in millions. LifeScan, Inc, sales topped $1,928 (in millions) during 2015, $2,142 in 2014, and $2,309 in 2013 (J & J, 2015).

Diabetes type 2 is a well-known disorder in America. It’s becoming one of the leading causes of premature morbidity and death worldwide. At Florida Hospital Diabetes and Translational Research Institute, Pratley (2013) stated that the prevalence of diabetes will continue to grow. It’s been estimated that by 2030 approximately 552 million adults will be affected mostly due to the growing of diabetes in developing countries. In the US alone, the number of people suffering from diabetes has drastically increased in the last 20 years because of the population being overweight or obese (Pratley, 2013). Those who are older in age, obese, have a family history of diabetes and lack of exercise have a higher chance of having it. The sooner people find

Imagine how hard it is for diabetics to have to prick their finger all day long. It would get very tiring, some diabetics have to test their blood sugar four times a day and two times at night. Which is why it would be so useful for them to have the Blood Sugar Watch. This device is a small watch-like device that diabetics will put on their wrist and it will tell them how high or how low their blood sugar is, the time, the person’s name, the date, and the scheduled time for the alarm to go off.

After each meal the electrodes will generate a current for about 10 minutes. It draws the glue near the surface of the skin and it allows the device to read the glucose levels. The glucose will then be carried by sodium ions that have a positive charge. This measures how strong the charge is underneath the skin. The sensors then estimate how much glucose is in the bloodstream. Researchers tested the device on seven nondiabetic people and have found that the tattoos glucose measurements were consistent with a traditional finger prick test method. A nano engineering graduate Amay Bandodkar, who was working on this stated that each temporary tattoo would work for up to five days and the cost that the user would incur will only be a few cents per tattoo. This device is an update on other devices like the Goca watch, it was released in 2002 and used electrochemical technology. The watch was never widely used because it caused skin irritation, but he notes that the tattoo would have the same effect as the watch, because they use a different method of measuring glucose as well as a lower electrical current. It is important to know that this is not the first time that researchers have tried to develop diabetic testing methods using tattoos. In 2010 a team at the Massachusetts Institute of Technology came up with a nano particle, that when it was injected below the skin and matched up with the sensor could monitor glucose for up to six months before there was a need for it to be refreshed. However this method was not tested on humans. Amay hopes to develop a sensor that functions continuously so that it can provide numerical readings of glucose levels. The team is also hopeful to expand the devices capabilities and perhaps offer other noninvasive ways to deliver medicine.However as with most things with their pros there also cons there is still a ways to go before

In early 2017, Medtronic started to market the first automatic insulin pump with a built-in glucose sensor. In the UK, researchers held in

Worcester, MA, October 11, 2016 – Our new product “GlucoGauge” – a blood glucose monitoring device, which just launched to the market, is purposed to provide convenience and high accuracy for our customers in tracking their own glucose levels each day. We expected that this new device would perform at its best with inaccuracy tolerance rate 10%, which is less than the FDA-mandate inaccuracy rate 20% and equal to ADA’s standard. Unfortunately, the physicians’ reports showed that the downloaded data on the patients’ glucose readings had an inaccuracy

Point of care diagnostics are medical tools or devices that can diagnose diseases in a community, which is usually in low resource environments. By moving disease diagnosis to the community level, point of care diagnostic devices can save patients money, because they will no longer travel to clinics and capable for earlier diagnosis. Point of care diagnostic systems gives regular standards of producing devices that time, accuracy and cost are reliable. For this purpose it is important that the biosensor be small, rapid and very simple to use. The low cost and ease of use application will increase the market economy. This increase will lead to expanded application in the clinical diagnostic environment. According to the World health organization,

Nurses also should check expiry date and give code to the strips accordingly. Baum et al., (2006) demonstrated that miscalibrated and miscoded glucose metres produced significant deviation from the actual values. It is demonstrated that more than 90 % errors in glucose estimation using glucometer were due to the improper handling of the glucometer by operator (Bergenstal, 2008). While using glucose metre, nurses should keep in mind that haematocrit interferes with the glucose levels (Balion et al., 2006). At the same time new glucometer was developed which can correct the haematocrit values while estimating the glucose level (Karon et al.,

I need a prescription from you to replace my blood glucose test meter. I have researched the available meters and the one I would like to have is the "Contour Next USB" . The USB is important to me. I also need the test strips for this meter.

The Bitfit needs to provide numerous applications and aids that replace multiple applications and recording devices making our product the easiest and most reliable health managing device within the market. Our advertising must justify our higher prices convincing consumers our product delivers the multiple tools monitoring health and wellness. We’ll need to provide various models from a basic Bitfit with the essentials to a deluxe version providing and replacing numerous applications providing the 24/7 accountability consumers are searching for. We need to establish demand then leverage our position with discounts on our higher end models but not lowering the overall price of all our products. Lowering price to meet surplus equilibrium will drive the demand down devaluing our product.

Mediquip S.A., a medical technologies company based in Europe, specializes in the sales of CT Scanners.  Within the market, they are at a disadvantage because many of their competitors have been there longer and know the decision-makers better.  Another difficulty for Mediquip S.A. is the relatively small market for CT Scanners which in Europe is about 200 units per year.